Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.15
0.04 (3.60%)
At close: Sep 05, 2025, 3:59 PM
1.16
0.85%
After-hours: Sep 05, 2025, 07:04 PM EDT
Allogene Therapeutics Revenue
Allogene Therapeutics reported an annual revenue of $22K, reflecting a -76.84% growth. For the quarter ending June 30, 2025, Allogene Therapeutics generated $0 in revenue.
Revenue (ttm)
22K
Revenue Growth
-76.84%
Price / Sales Ratio
18861.34
Revenue / Employee
97.35
Employees
226
Market Cap
255.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 22K | -76.84% |
| Dec 31, 2023 | 95K | -39.10% |
| Dec 31, 2022 | 156K | -99.86% |
| Dec 31, 2021 | 114.09M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |